To investigate the association between patients' social risk factors and the risk of tuberculous infection and TB disease among their contacts in England. Evaluating clinical and social needs by assessment of the enhanced case management (ECM) level is one method of identifying high-risk TB cases. 3 In North West England, TB specialist nurses evaluate the clinical and social needs of TB patients and assign an ECM level from 0 (standard case management) to 3 (complex needs requiring the highest level of intensive support), which is subsequently reassessed during multidisciplinary TB cohort review (known as TB cohort audit [TBCA] in North West England). 4 The ECM offered varies according to the needs of each household, but can include intensive support from ancillary services and partner organisations, more frequent clinic or home visits, and transport vouchers or translation services to overcome language barriers. Table 1 provides a summary of the guide to the classification of patients to ECM levels used in TB cohort reviews. As a general rule, a patient's overall ECM level will be classified according to his/her highest level of need across three domains: clinical factors, TB-specific factors and social factors (Table 1) . For example, if a patient's social factors are scored as ECM level 3 and his/her clinical and TB-specific factors are scored as ECM level 2, the patient's overall ECM level will be 3.
The social complexity and ethnicity of patients were associated with tuberculous infection and TB disease in their contacts. K E Y W O R D S : TB; contact screening; TB prevention; TB control; enhanced case management; social and clinical complexity; public health DESPITE DECLINING TUBERCULOSIS (TB) rates in England, 1, 2 there has been an increase in the proportion of TB cases with complex clinical and social needs. 2 Identifying cases and their household contacts, and providing enhanced TB care where appropriate, are key components of the Public Health England and National Health Service England Collaborative Tuberculosis Strategy 2015-2020. 2 Evaluating clinical and social needs by assessment of the enhanced case management (ECM) level is one method of identifying high-risk TB cases. 3 In North West England, TB specialist nurses evaluate the clinical and social needs of TB patients and assign an ECM level from 0 (standard case management) to 3 (complex needs requiring the highest level of intensive support), which is subsequently reassessed during multidisciplinary TB cohort review (known as TB cohort audit [TBCA] in North West England). 4 The ECM offered varies according to the needs of each household, but can include intensive support from ancillary services and partner organisations, more frequent clinic or home visits, and transport vouchers or translation services to overcome language barriers. Table 1 provides a summary of the guide to the classification of patients to ECM levels used in TB cohort reviews. As a general rule, a patient's overall ECM level will be classified according to his/her highest level of need across three domains: clinical factors, TB-specific factors and social factors (Table 1) . For example, if a patient's social factors are scored as ECM level 3 and his/her clinical and TB-specific factors are scored as ECM level 2, the patient's overall ECM level will be 3.
Close contacts of TB patients are known to have an increased risk of prevalent latent tuberculous infection (LTBI) and active TB disease. 1 Contact tracing and preventive therapy are well-established, important tools in TB prevention, particularly for underserved households in which patients and contacts share similar social and/or clinical risk factors. 5 However, there is minimal evidence concerning whether patients' social or clinical risk factors, including ECM level and ethnicity, can predict rates of prevalent LTBI and active TB disease in their household contacts. We aimed to fill this knowledge gap.
METHODS

Study design
A retrospective cohort study in North West England.
Data source
Patient data were collected using Public Health England's national Enhanced TB Surveillance (ETS) system and supplemented by complementary North West TBCA data. Neither ETS nor TBCA contains individual-level data about patients' contacts. The contact data entered into ETS include the total number of contacts identified per patient and, among these, the number of contacts who were screened for LTBI or active TB disease, diagnosed with LTBI or active TB disease, started on preventive therapy for LTBI, and those who completed preventive therapy for LTBI. Data were not available concerning the treatment or treatment outcomes of contacts diagnosed with active TB disease, or the contact screening and LTBI diagnostic methods used (e.g., symptom screening, chest radiograph, microbiological testing of sputum samples, the tuberculin skin test and interferon-gamma release assay).
Eligibility
Participants were TB cases of any age from North West England with microbiologically or clinically confirmed pulmonary or extra-pulmonary TB disease notified to ETS between 27 March 2012 and 28 June 2016, with a defined ECM level, and at least one identified contact.
Outcomes
The primary outcome was the prevalence of LTBI or of active TB disease and a positive screening outcome (sum of LTBI and active TB disease) in the contacts of failure to attend at clinics, consistently not home for reviews patients as entered into the ETS database. The secondary outcome was identification of the specific social and clinical risk factors of patients who were independently associated with LTBI and active TB disease in their contacts.
Analysis
For the primary outcome, prevalence of LTBI or of active TB disease and a positive screening outcome in contacts were calculated and compared across their index patients' ECM levels using the v 2 test for trend and between each ECM level using the v 2 test. The number of contacts needed to screen (NNS) to detect one case of LTBI or active TB disease, or a positive screening outcome was also calculated.
For the secondary outcome, we used a multivariable logistic regression model to estimate odds ratios adjusted for potential confounders of contacts' LTBI and active TB disease prevalence according to their index patient's social and clinical risk factors (sex, age, ECM level, ethnicity, sputum smear positivity and postcode-associated index of multiple deprivation score).
Statistical analyses were performed using Stata v 12 (StataCorp, College Station, TX, USA) and R v 3.5.0 (R Foundation for Statistical Computing, Vienna, Austria).
Ethics
As anonymised, routinely collected public health surveillance data were used, participant consent was not sought. This study is part of wider evaluations approved by the UK North West TB Cohort Audit Steering Group, which reports to the UK North West TB Control Board.
RESULTS
During the study period, 2139 TB cases met eligibility criteria, and had 10 019 household contacts screened (median 4, interquartile range [IQR] 2-6, range 1-24). Of 2139 TB cases, 949 (44%) were categorised as ECM-0, 660 (31%) as ECM-1, 303 (14%) as ECM-2 and 227 (11%) as ECM-3. Patients with higher ECM levels were more likely to: have smearpositive pulmonary TB, be White and UK-born, be unemployed, and have more contacts identified per patient ( Table 2 ). The most prevalent social and clinical risk factors contributing to higher ECM levels were being clinically complex, having a language barrier and being considered at risk of poor adherence to TB medications ( Table 2) . Contacts of patients with higher ECM levels were less likely to complete preventive therapy once initiated (Table 2) .
Compared with the contacts of ECM-0 patients, contacts of patients with higher ECM levels were significantly more likely to have prevalent active TB disease (ECM-3: 4.2%, 95%CI 2.4-6.0 vs. ECM-0: 1.1%, 95%CI 0.1-1.16, P , 0.001 test for trend), LTBI (ECM-3: 10%, 95%CI 7.0-13 vs. ECM-0: 5.7%, 95%CI 4.6-6.8; P , 0.001) and a positive screening outcome (ECM-3: 14%, 95%CI 10-17 vs. 2 test for trend across ECM levels, which was P , 0.001 for LTBI, active TB disease and positive screening outcome respectively. Error bars are the 95%CIs for the proportion of contacts with positive screening outcome across ECM levels. A sensitivity analysis was performed excluding patients in whom ECM levels were calculated on the basis of poor adherence or having child contacts. Proportions of assessed contacts with LTBI in the sensitivity analysis were as follows: total (n ¼ 860) 5.9% (95%CI 4.5-7.2); ECM 0 (n ¼ 391) 6.3% (95%CI 4.2-8.4); ECM 1 (n ¼ 255) 6.5% (95%CI 3.8-9.1); ECM 2 (n ¼ 132) 3.3% (95%CI 1.1-5.6); ECM 3 (n ¼ 82) 6.0% (95%CI 1.8-10); P ¼ 0. ECM-0: 6.8%, 95%CI 5.5-7.9; P , 0.001; Figure 1 ). Comparing ECM-3 with ECM-0, NNS to identify one case of active TB disease was respectively 24 vs. 91, to identify one case of LTBI was 10 vs. 19 and to identify one positive screening outcome was 7 vs. 15 ( Figure 1 ). Multivariable logistic regression showed that sputum smear positivity, higher ECM level or Black Caribbean ethnicity of patients were independently associated with their contacts' risk of active TB disease 
DISCUSSION
A simple risk stratification score generated by the TB multidisciplinary team at TBCA was implemented in North West England to estimate the ECM need of TB cases. Contacts of TB patients with a higher ECM level-and therefore, greater clinical and social complexity-and/or Black Caribbean ethnicity were more likely to have LTBI and active TB disease. Evaluation of the social and clinical risk factors of TB patients and estimation of their ECM level can be useful indicators of risk of a positive TB screening outcome among their contacts. Such evaluation could be used to prioritise contact tracing resources towards high-risk households to potentially enhance the effectiveness of TB prevention measures.
In high-income countries, ECM in high-risk TB patients, including those who use drugs and/or are homeless, has been shown to reduce poor adherence, loss to follow-up and death. 6.7 Our previous research from North West England has shown that patients with higher ECM levels are more likely to have adverse TB treatment outcomes, despite the mitigating effects of enhanced TB care. 4 Our new findings suggest that not only may TBCA and ECM be vital in identifying patients who require additional support to achieve TB treatment success, but that these can also be used to indirectly estimate the needs of the close contacts of these patients. This is important because contact tracing and provision of preventive therapy are well-established, important tools in TB prevention, and enhanced support is required not only for high-risk TB patients but also for their households. 2, 5 Multiple scoring systems have been developed to estimate the risk of LTBI and active TB disease in the close contacts of TB patients. In Taiwan, an eight-point contact risk assessment scoring system was developed and validated to identify child contacts at risk of developing active TB disease. 8 In Peru, social and clinical risk factors such as body mass index, previous TB, level of exposure, poverty, indoor air pollution and ventilation were used to derive and validate a scoring system to estimate the risk of developing TB disease in adult contacts. 9 In Uganda, a modified version of the World Health Organization's pragmatic screening algorithm for the child (age ,16 years) contacts of adult TB cases was used to identify children at high risk of asymptomatic, subclinical TB disease. 10 However, these risk scores all rely on individuallevel data on each contact's risk factors, which are not currently collected by England's ETS system or the North West's regional TBCA. The results of our analysis of ECM are the first to show that patients' ECM risk stratification and other patient characteristics, including ethnicity, can be applied to estimate the risk of LTBI and active TB disease in their household contacts.
Our study had several limitations. First, TBCA mostly occurred following treatment initiation, and variables contributing to ECM classification include confounding factors such as patients having poor adherence to anti-tuberculosis treatment or having child contacts, both of which are known to be associated with a higher risk of LTBI and active TB disease. 9 To overcome this limitation, we performed a sensitivity analysis in which we excluded those patients assigned ECM levels 1-3 with poor adherence to antituberculosis treatment or a child contact. The sensitivity analysis was broadly consistent with the original analysis and is shown in Figure 1 . Second, the ETS and TBCA data used for analysis were limited to patients from North West England. Findings may thus not be generalisable to other regions of England or worldwide. Third, ETS and TBCA data concerning contacts were limited to aggregate data because individual-level data (e.g., sociodemographic variables, and screening and LTBI preventive therapy outcomes of each individual contact) were not recorded. The lack of such contact data is a weakness of the current ETS and TBCA system, and it will be important to consider inclusion of more detailed (and individualised) TB prevention and control activities in future iterations of both as England and the United Kingdom progress towards TB elimination. Fourth, we could not elucidate whether the LTBI or active TB disease identified in household contacts was attributable to recent transmission of TB from the index case because no longitudinal tuberculin skin test or interferongamma release assay results were available and no genotyping data used. Finally, the number of TB cases with Black Caribbean ethnicity in the region was small (n ¼ 11). Although statistically significant, the association found between Black Caribbean ethnicity and likelihood of LTBI or active TB disease therefore has a high degree of uncertainty (reflected by the wide CIs, seen in Figure 2 ) and should be interpreted with caution. Further studies with a larger cohort of TB cases are necessary to confirm this finding.
CONCLUSION
In North West England, the contacts of TB patients with higher social and clinical complexity, measured using a simple ECM evaluation or having Black Caribbean ethnicity, had greater odds of LTBI and active TB disease prevalence. These findings support the role of TBCA and ECM evaluation in North West England and can contribute to pragmatic prioritisation of the TB multidisciplinary workforce to reach TB-affected households with the greatest need. As England progresses towards the goal of TB elimination, such prioritisation could enhance the efficiency of constrained TB prevention resources. Fue este un estudio de cohortes de todos los casos de tuberculosis (TB) de la Región del Noroeste de la Inglaterra diagnosticados del 27 de marzo del 2012 al 28 de junio del 2016. Se obtuvieron datos a partir del sistema nacional de vigilancia reforzada de la TB (ETS) y del examen de la cohorte de TB de la Región del Noroeste, durante el cual se evaluaron los factores de riesgo sociales de los casos de TB, con el fin de estimar las necesidades para la iniciativa de reforzar la gestión de casos (ECM), desde el nivel ECM 0 (normas asistenciales corrientes) hasta el nivel ECM 3 (apoyo social intensivo). R E S U LTA D O S: Cumplieron los criterios de selección 2139 casos y sus 10 019 contactos. Los factores asociados de manera independiente con una mayor probabilidad de padecer TB activa fueron el hecho de ser contacto de un paciente tuberculoso con baciloscopia positiva (baciloscopia positiva contra baciloscopia negativa: OR 5,3; IC95% 3,2-8,7); asignado a un ECM de alto nivel (ECM 3 contra ECM 0: OR 2,2; IC95% 1,01-5,0); o perteneciente a la etnia afrocaribeña (afrocaribeña contra blanca: OR 7,4; IC95% 2,1-25). Se asociaron con una mayor probabilidad de contraer la infección tuberculosa el hecho de ser contacto de un paciente tuberculoso con baciloscopia positiva (baciloscopia positiva contra baciloscopia negativa: OR 5,3; IC95% 3,8-7,3); o de origen afrocaribeño (etnia afrocaribeña contra blanca: OR 6,7; IC95% 2,0-25). C O N C L U S I O N E S: La complejidad de la situación social de los pacientes y su etnia se asociaron con la aparición de infección tuberculosa y enfermedad activa en sus contactos.
